what do glp-1 agonists do Can one drug it all? Reviewing the expanding clinical universe of Exploring the Side Effects of

A core highlight includes the Phase 3 ACHIEVE trial results for Foundayo, an oral small-molecule GLP-1 receptor agonist taken without food or water restrictions

It is acceptable to change the day of weekly use as long as there is at least a two-day interval between two doses

(average results) Wegovy (semaglutide) GLP-1 only In the STEP-1 study (68 weeks), average weight change was about: 14.9% with Wegovy 2.4% with placebo (dummy injection) What that looks like: If you start at 100 kg , 14.9% is about 15 kg lost on average

A 2023 study revealed that theres a slightly increased risk for intestinal obstruction (when your intestines cant contract, making it hard to get rid of waste), because semaglutide slows down food as it travels through your digestive system (17)

GLP-1 therapies designed to treat type 2 diabetes, and used as a popular weight loss tool, may have the potential to treat more than overeating as experts now believe medications such as Ozempic, Wegovy, and Mounjaro could help to crush other bad habits such as alcohol and substance abuse